Does the Brain Build Tolerance to THC's Memory-Disrupting Effects?

This was an animal study using rats treated with chronic THC (5 mg/kg intraperitoneally, twice daily for two weeks). Researchers measured hippocampal extracellular acetylcholine concentrations using microdialysis and assessed spatial memory using T-maze alternation tasks. The CB1 antagonist SR 141716A was used to confirm receptor specificity.

Tolerance is a key factor in both the therapeutic potential and abuse liability of any drug. The finding that tolerance did not develop to THC's cognitive and cholinergic effects, even while tolerance develops to other THC effects like sedation, suggested that these impacts on memory could be persistent with ongoing use. The different timescales also indicated that memory impairment and acetylcholine reduction, while both CB1-mediated, may involve distinct neural mechanisms.

This study contributed to understanding why cognitive effects of cannabis may persist in regular users even as other effects diminish with tolerance. The hippocampal acetylcholine system is critical for memory formation, and the finding that THC persistently suppresses it through CB1 receptors has implications for understanding cannabis-related cognitive complaints in human users.

Animal studies using injected THC at fixed doses do not directly replicate human cannabis use patterns. The two-week treatment period may not capture longer-term tolerance development. Rat cognitive tests like T-maze alternation assess a limited form of spatial memory that does not encompass the full range of human cognitive functions.